PCK 0.00% 3.2¢ painchek ltd

Media Thread, page-958

  1. 27,705 Posts.
    lightbulb Created with Sketch. 1788
    Why not just make the facial assessment required then as it will be a much easier to sell the product as a totally objective assessment....?? The clinical trial they used to gain regulatory approval clearly show even some of the independent RCA has to do the manual assessments as the EPAT user weren't familiar with APS.
 
watchlist Created with Sketch. Add PCK (ASX) to my watchlist
(20min delay)
Last
3.2¢
Change
0.000(0.00%)
Mkt cap ! $52.39M
Open High Low Value Volume
3.2¢ 3.2¢ 3.2¢ $5.469K 170.9K

Buyers (Bids)

No. Vol. Price($)
2 44930 3.2¢
 

Sellers (Offers)

Price($) Vol. No.
3.4¢ 108791 1
View Market Depth
Last trade - 14.22pm 06/11/2024 (20 minute delay) ?
PCK (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.